Skip to main content
logo
Vaxart, Inc. (VXRT)
OTCMKTS · Delayed Price · Currency is USD
0.3926
-0.0074 (-1.85%)
Aug 7, 2025, 3:58 PM EDT

Aspen Technology Revenue

Vaxart had revenue of $20.88M in the quarter ending March 31, 2025, with 857.18% growth. This brings the company's revenue in the last twelve months to $47.40M, up 433.43% year-over-year. In the year 2024, Vaxart had annual revenue of $28.70M with 288.94% growth.

Revenue (ttm)
47.40M
Revenue Growth
+433.43%
P/S Ratio
1.88
Revenue / Employee
451.38K
Employees
105
Market Cap
89.13M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202428.70M21.32M288.94%
Dec 31, 20237.38M7.27M6,796.26%
Dec 31, 2022107.00K-785.00K-88.00%
Dec 31, 2021892.00K-3.15M-77.95%
Dec 31, 20204.05M-5.82M-58.97%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Veradigm588.02M
Tian'an Technology Group1.78M
Elite Pharmaceuticals84.04M
Glass House Brands215.62M
Northwest Biotherapeutics1.47M
American Oncology Network1.76B
Silence Therapeutics27.70M
BioStem Technologies332.45M
Revenue Rankings

Vaxart News

More News